Skip to content

Investigating the efficacy of add-on acceptance and commitment therapy in the inpatient setting for depression and sleep disorders - a randomized controlled trial

Investigating the efficacy of add-on acceptance and commitment therapy in the inpatient setting for depression and sleep disorders - a randomized controlled trial

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00032242
Enrollment
100
Registered
2023-07-11
Start date
2023-07-17
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

F32.0 F32.1 F32.2 F33.0 F33.1 F33.2

Interventions

Group 1: Intervention group "Treatment as usual + ACT-based add-on therapy for depression and sleep disorders": In addition to an inpatient treatment program (including psychopharmacological therapy,

Sponsors

Klinikum Christophsbad - Christophsbad Akademie für Psychotherapie (C-AP) Forschungssektion für Angewandte Psychotherapie und Psychiatrie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: German fluent in spoken and written language

Exclusion criteria

Exclusion criteria: Reduction of intelligence according to clinical impression Acute suicidality Acute danger to others Acute self-harm Acute psychotic symptoms Bipolar disorders (current or past episodes) Schizophrenic disorders (current or past) Presence of a dependency disorder Biological therapy procedures: Electroconvulsive therapy (ECT) and esketamine treatment (Spravato) Presence of hypersomnia Suspected or presence of obstructive sleep apnea syndrome

Design outcomes

Primary

MeasureTime frame
Depressive Symptomatology (Self-Assessment) (BDI-II) Depressive Symptomatology (Observer Rating) (GRID-HAMD) Subjective sleep problems (RIS) 3 measurement time points: T1 (baseline: 1 week before intervention), T2 (post measurement: 1 week after completion of intervention), T3 (follow-up measurement: 3 months after completion of intervention).

Secondary

MeasureTime frame
Psychological flexibility (FAH-II) Acceptance of sleep problems (SPAQ) Subjective quality of life (WHOQOL-BREF) 3 measurement time points: T1 (baseline: 1 week before intervention), T2 (post measurement: 1 week after completion of intervention), T3 (follow-up measurement: 3 months after completion of intervention).

Countries

Germany

Contacts

Public ContactMax Bergmann

Klinikum Christophsbad - Christophsbad Akademie für Psychotherapie (C-AP) Forschungssektion für Angewandte Psychotherapie und Psychiatrie

max.bergmann@christophsbad.de07161 601 8671

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Aug 9, 2026